Abaloparatide 3mg

Abaloparatide 3 mg is supplied as a high-purity lyophilized peptide research compound intended exclusively for scientific and laboratory applications. For research use only — not for human or veterinary use.  

Product Overview

Abaloparatide is a synthetic peptide research compound widely studied in controlled laboratory environments focused on peptide-receptor interactions, cellular signalling pathways and endocrine regulatory mechanisms. The compound has attracted significant scientific interest due to its defined amino acid sequence, well-characterised molecular structure and extensive use within peptide-focused research models. This preparation contains 3 mg of lyophilized Abaloparatide supplied in a sealed research vial. Lyophilization helps preserve compound stability during storage and allows researchers to reconstitute the peptide for controlled laboratory experimentation. Due to its established analytical profile and growing presence within scientific literature, Abaloparatide remains a recognised compound within modern peptide research.  

Peptide Overview

Abaloparatide is a synthetic peptide analogue studied in experimental laboratory settings for its interaction with receptor-mediated signalling systems and molecular communication pathways. Researchers frequently investigate the peptide in controlled models examining cellular signalling mechanisms, peptide-receptor dynamics and endocrine regulatory networks. The compound’s defined structure and reproducible analytical characteristics have contributed to its continued relevance within peptide-related scientific investigation. Today, Abaloparatide is incorporated into numerous research programmes exploring peptide-mediated biological communication and molecular regulation.  

Historical Background and Scientific Context

Scientific interest in synthetic peptide analogues expanded considerably during the late twentieth and early twenty-first centuries as advances in peptide chemistry enabled the development of increasingly sophisticated research compounds. These developments allowed researchers to investigate receptor-specific peptide interactions and molecular signalling mechanisms under highly controlled laboratory conditions. Abaloparatide emerged from this broader field of peptide innovation and has since become a recognised compound within peptide-focused scientific research. Its continued study contributes to a growing body of literature examining peptide signalling systems and molecular communication pathways.  

Mechanistic Focus in Research

Within controlled laboratory environments, Abaloparatide is commonly studied in relation to receptor-mediated peptide signalling and intracellular communication pathways. Research investigations frequently explore the compound in experimental models examining:

• Peptide-receptor interaction dynamics
• Cellular signalling pathways
• Intracellular communication systems
• Molecular regulatory mechanisms
• Endocrine signalling networks
• Comparative peptide pathway analysis
• Receptor-mediated biological responses

These experimental approaches allow researchers to investigate complex molecular processes associated with peptide-mediated signalling.  

Analytical Verification (COA)

Each batch of Abaloparatide supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric and mass spectrometry techniques. Batch: GF-ABALP3-B241

• Assay Content: 2.91 mg
• Purity: greater than 99.8 percent
• Identification by Retention Time: 0.994
• Identification by FTIR Spectrum: 991
• Molecular Ion Mass Identification: 3961 Da
• Bacterial Endotoxins: 0.048 EU/mg
• Total Aerobic Microbial Count: Not detected
• Total Yeast and Mold Count: Not detected

Independent elemental impurity screening confirmed no detectable arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures provide confirmation of identity, purity, traceability and batch consistency for laboratory research applications. :contentReference[oaicite:0]{index=0}  

Research Applications

In controlled laboratory environments, Abaloparatide may be utilised in experimental models designed to investigate peptide signalling systems and receptor-mediated molecular pathways. Examples of research applications include:

• Peptide signalling pathway investigations
• Receptor interaction analysis
• Molecular communication studies
• Cellular signalling research
• Comparative peptide investigations
• Endocrine pathway modelling
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific investigation and laboratory experimentation.  

Grail Formula Quality

Every Grail Formula research compound is supported by extensive independent analytical verification and full batch traceability. Each batch undergoes testing for:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular mass verification
• Endotoxin analysis
• Microbial contamination screening
• Heavy metal screening
• Batch traceability

Independent testing helps ensure consistent laboratory-grade research material suitable for controlled scientific applications.  

When You Choose Grail Formula

When selecting Grail Formula, researchers gain access to independently verified research compounds supported by detailed Certificates of Analysis and transparent batch-specific testing. Our commitment to quality includes publication of purity data, assay verification, identity confirmation, endotoxin screening, microbial testing, elemental impurity analysis and molecular mass verification. Every batch is supported by a downloadable COA issued by Liquilabs s.r.o. Czechia, providing full traceability and independent laboratory verification.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• Purity greater than 99.8 % confirmed by COA
• Assay content verified at 2.91 mg
• Molecular ion mass identified at 3961 Da
• Endotoxin level measured at 0.048 EU/mg
• No detectable heavy metals or microbial contamination
• Abaloparatide peptide research compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.